Abvc Biopharma (ABVC) Share-based Compensation (2010 - 2026)
Abvc Biopharma (ABVC) posted Share-based Compensation of $253,041 for Q2 2026, down 83.9% from $1.57 million a year earlier and down 67.9% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Share-based Compensation (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Abvc Biopharma was $3.56 million, up 71.3% year-over-year; for FY2025, it was $4.14 million, up 49.4% from FY2024.
- Annual Share-based Compensation shows a four-year compound annual growth rate of -6.0% (FY2021 to FY2025).
- In prior years, Abvc Biopharma's Share-based Compensation was $2.77 million in FY2024, $185,933 in FY2023 (-97.4%), $7.04 million in FY2022 (+32.6%) and $5.31 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q1 2025.
- On a year-over-year basis, Share-based Compensation increased in two of the last five quarters, with growth averaging 93.5%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $787,374 (Q1 2026), $1.39 million (Q4 2025) and $1.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 253,041.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 253,041.00 |
| Mar 31, 2026 | 787,374.00 |
| Dec 31, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.57 Mn |
| Mar 31, 2025 | 48,773.00 |
| Dec 31, 2024 | 363,079.00 |
| Sep 30, 2024 | 95,875.00 |
| Jun 30, 2024 | 282,875.00 |
| Mar 31, 2024 | 2.03 Mn |
| Dec 31, 2023 | -1.22 Mn |
| Sep 30, 2023 | 817,740.00 |
| Jun 30, 2023 | 225,740.00 |
| Mar 31, 2023 | 366,489.00 |
| Mar 31, 2019 | 8,550.00 |
| Dec 31, 2018 | 5,399.00 |
| Sep 30, 2018 | 7,575.00 |
| Jun 30, 2018 | 10,200.00 |
| Mar 31, 2018 | 5,626.00 |
| Sep 30, 2017 | 132,110.00 |
API Access
Abvc Biopharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();